Evidence map›Paper›PMID 41149498›Full record

ArticleCurrent oncology (Toronto, Ont.)2025

Comparative Prognostic Roles of β-Catenin Expression and Tumor-Stroma Ratio in Pancreatic Cancer: Neoadjuvant Chemotherapy vs. Upfront Surgery.

Shu Oikawa, Hiroyuki Mitomi, So Murai, Akihiro Nakayama, Seiya Chiba, Shigetoshi Nishihara, Yu Ishii, Toshiko Yamochi, Hitoshi Yoshida

Abstract readComparative Study
In one paragraph

Article in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shu OikawaDepartment of Medicine, Division of Gastroenterology, Showa Medical University School of Medicine, Tokyo 142-8555, Japan.ORCID 0000-0001-7242-1734
Hiroyuki MitomiDepartment of Diagnostic Pathology, Showa Medical University School of Medicine, Tokyo 142-8555, Japan.ORCID 0009-0002-5163-4137
So MuraiDepartment of Diagnostic Pathology, Showa Medical University School of Medicine, Tokyo 142-8555, Japan.ORCID 0009-0007-6908-5056
Akihiro NakayamaDepartment of Medicine, Division of Gastroenterology, Showa Medical University School of Medicine, Tokyo 142-8555, Japan.
Seiya ChibaDepartment of Diagnostic Pathology, Showa Medical University School of Medicine, Tokyo 142-8555, Japan.ORCID 0009-0008-4852-2541
Shigetoshi NishiharaDepartment of Medicine, Division of Gastroenterology, Showa Medical University School of Medicine, Tokyo 142-8555, Japan.ORCID 0000-0002-8320-4994
Yu IshiiDepartment of Medicine, Division of Gastroenterology, Showa Medical University School of Medicine, Tokyo 142-8555, Japan.ORCID 0000-0003-2069-1753
Toshiko YamochiDepartment of Diagnostic Pathology, Showa Medical University School of Medicine, Tokyo 142-8555, Japan.ORCID 0009-0006-5610-752X
Hitoshi YoshidaDepartment of Medicine, Division of Gastroenterology, Showa Medical University School of Medicine, Tokyo 142-8555, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The benefit of neoadjuvant chemotherapy (NAC) over upfront surgery (UFS) for resectable pancreatic ductal adenocarcinoma (PDAC) is increasingly recognized, yet prognostic biomarkers remain undefined. We evaluated tumor-stroma ratio (TSR), β-catenin (β-CTN) expression, and tumor budding (TB) in 84 resected PDACs (35 NAC, 49 UFS) using digital image analysis of multi-cytokeratin (m-CK) and β-CTN immunohistochemistry. TSR was defined as the proportion of malignant epithelial area within the tumor, and the β-CTN/m-CK index as the ratio of β-CTN to m-CK immunoreactivity in tumor tissue relative to intralobular ducts. TB was significantly less frequent in NAC than UFS (

Indexed as

beta CateninCarcinoma, Pancreatic DuctalPancreatic NeoplasmsAdultAgedBiomarkers, TumorFemaleHumansMaleMiddle AgedNeoadjuvant TherapyPrognosisbeta CateninBiomarkers, TumorCTNNB1 protein, humandigital image analysisimmunohistochemistryneoadjuvant chemotherapypancreatic ductal adenocarcinomatumor buddingtumor–stroma ratioupfront surgerywhole-slide imagingβ-catenin

Identifiers

PMID41149498
PMCPMC12563957

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.